BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8418376)

  • 41. Descriptive epidemiology of de novo acute leukaemia in the Sultanate of Oman.
    Knox-Macaulay HH; Brown LC
    Leuk Res; 2000 Jul; 24(7):589-94. PubMed ID: 10867133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunophenotyping of childhood acute lymphoblastic leukemia in Saudi Arabia: second look.
    Khalil SH; Qari MH; Jackson JM; Pyle RH; el-Solh H; al-Nasser A
    Leuk Res; 1994 Dec; 18(12):881-3. PubMed ID: 7996868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of high-dose methylprednisolone and G-CSF treatments on lymphocyte subtypes in neutropenic children with acute lymphoblastic leukemia: a pilot study.
    Ozbek N; Yetgin S; Tuncer AM
    Pediatr Hematol Oncol; 1998; 15(6):539-44. PubMed ID: 9842648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of childhood leukaemia with factors related to the immune system.
    Schüz J; Kaletsch U; Meinert R; Kaatsch P; Michaelis J
    Br J Cancer; 1999 May; 80(3-4):585-90. PubMed ID: 10408870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An analysis of prognostic variables in acute lymphocytic leukaemia in a heterogenous South African population.
    Wessels G; Hesseling PB; Buurman M; Oud C; Nel ED
    J Trop Pediatr; 1997 Jun; 43(3):156-61. PubMed ID: 9231636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The age incidence of childhood acute lymphoblastic leukaemia.
    Morris JA
    Med Hypotheses; 1991 May; 35(1):4-10. PubMed ID: 1921776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunophenotype of acute lymphoblastic leukemia in minorities- analysis from the SEER database.
    Quiroz E; Venkateswaran AR; Nelson R; Aldoss I; Pullarkat V; Rego E; Marcucci G; Douer D
    Hematol Oncol; 2022 Feb; 40(1):105-110. PubMed ID: 34766363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progress against childhood and adolescent acute lymphoblastic leukaemia in the Netherlands, 1990-2015.
    Reedijk AMJ; Coebergh JWW; de Groot-Kruseman HA; van der Sluis IM; Kremer LC; Karim-Kos HE; Pieters R
    Leukemia; 2021 Apr; 35(4):1001-1011. PubMed ID: 32820270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunophenotype-defined sub-populations are common at diagnosis in childhood B-cell precursor acute lymphoblastic leukemia.
    Øbro NF; Marquart HV; Madsen HO; Ryder LP; Andersen MK; Lausen B; Albertsen BK; Wehner PS; Helgestad J; Schmiegelow K
    Leukemia; 2011 Oct; 25(10):1652-7. PubMed ID: 21681192
    [No Abstract]   [Full Text] [Related]  

  • 50. Features of childhood leukaemia in Tanzania.
    Grimes C; Schimana W
    Trop Doct; 2007 Apr; 37(2):117. PubMed ID: 17540103
    [No Abstract]   [Full Text] [Related]  

  • 51. Childhood leukaemia incidence around French nuclear installations using geographic zoning based on gaseous discharge dose estimates.
    Evrard AS; Hémon D; Morin A; Laurier D; Tirmarche M; Backe JC; Chartier M; Clavel J
    Br J Cancer; 2006 May; 94(9):1342-7. PubMed ID: 16622448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of infection in childhood leukemia: what can be learned from the male predominance?
    Rechavi G; Ramot B; Ben-Bassat I
    Acta Haematol; 1992; 88(2-3):58-60. PubMed ID: 1466202
    [No Abstract]   [Full Text] [Related]  

  • 53. [Immunophenotyping of acute lymphoblast leukosis in children].
    Baldueva IA; Belogurova MB
    Klin Lab Diagn; 1997 Nov; (11):46-7. PubMed ID: 9471324
    [No Abstract]   [Full Text] [Related]  

  • 54. Epidemiology of acute leukaemia in the Cape Province of South Africa.
    Sayers GM; Rip MR; Jacobs P; Klopper JM; Karabus CD; Rosenstrauch WJ; Hesseling PB; Hoffman M; Sayed R
    Leuk Res; 1992 Oct; 16(10):961-6. PubMed ID: 1405709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ki67 expression in childhood acute lymphoblastic leukaemia and relation with L2 morphology.
    Cantu'-Rajnoldi A; Banfi P; Castagni M; Valeggio C; Masera G
    Br J Haematol; 1989 Feb; 71(2):302-3. PubMed ID: 2923819
    [No Abstract]   [Full Text] [Related]  

  • 56. Clustering of childhood acute leukaemia: The EUROCLUS Project.
    Alexander F
    Radiat Environ Biophys; 1998 Jul; 37(2):71-4. PubMed ID: 9728737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Childhood leukaemia relapse risk factors. A rough sets approach.
    Podraza W; Podraza H
    Med Inform Internet Med; 1999; 24(2):91-108. PubMed ID: 10399708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of some simple methods to identify geographical areas with excess incidence of a rare disease such as childhood leukaemia.
    Wray NR; Alexander FE; Muirhead CR; Pukkala E; Schmidtmann I; Stiller C
    Stat Med; 1999 Jun; 18(12):1501-16. PubMed ID: 10398288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fallon leukaemia cluster findings, research plans announced.
    Furlow B
    Lancet Oncol; 2007 Jan; 8(1):9. PubMed ID: 17348115
    [No Abstract]   [Full Text] [Related]  

  • 60. Absence of leukaemia clustering on Greek islands.
    Petridou E; Hsieh CC; Kotsifakis G; Skalkidis Y; Trichopoulos D
    Lancet; 1991 Nov; 338(8776):1204-5. PubMed ID: 1682610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.